1.Cognitive Enhancers in AAMI.
Journal of Korean Geriatric Psychiatry 2001;5(1):25-35
No abstract available.
Nootropic Agents*
2.A Case of Presenile Alzheimers Dementia: 3 Year Neurocognitive Function and Behavioural Changes.
Byoung Hoon OH ; Chang Il LEE ; Yoon Young NAM
Journal of Korean Geriatric Psychiatry 2000;4(1):101-105
Alzheimer's disease (AD) is the most typical progressive and irreversible dementia characterized by loss of intellectual capacity in many domains, altered behavior, inability to care for oneself, and ultimately neurologic abnormalities. In the treatment of AD, the focus is limited to relief of cognitive and behavioral symptoms. But the choice of adequate treatment according to severity level is difficult task for maintaining patient's quality of life. We experienced a case of typical presenile Alzheimer's disease who progressed severe dementia while being treated with cognitive enhancers and psychosocial intervention for three years. In review of this case, we conclude that early detection and active treatment of presenile dementia is most important factor for delaying of progress and decreasing of family burden.
Alzheimer Disease
;
Behavioral Symptoms
;
Dementia*
;
Humans
;
Nootropic Agents
;
Quality of Life
3.Progress of research on effects of ginsenoside Rg1 in promoting capability of learning and memory.
Ying LIU ; Xi LI ; Hai-feng YUAN
Chinese Journal of Integrated Traditional and Western Medicine 2006;26(10):956-960
It is testified by long-standing traditional Chinese medicine clinical practice that ginseng was effective in treating dementia and promoting capability of learning and memory, for which ginsenoside Rg1 has been proved the main effective ingredient. Recently many researches have been carried out on the mechanism and action links of ginsenoside Rg1, and illustrated that it could exert the anti-dementia and nootropic effects through intervening multiple targets and links, thus to provide a theoretical basis for bettering the clinical use of ginsenoside Rg1.
Animals
;
Ginsenosides
;
pharmacology
;
Humans
;
Learning
;
drug effects
;
Memory
;
drug effects
;
Neuronal Plasticity
;
drug effects
;
Nootropic Agents
;
pharmacology
4.Korean Traditional Medicines as Novel Drugs for Neuropsychiatric Disorders.
Sung Kil MIN ; Chang Hyung HONG
Korean Journal of Psychopharmacology 2007;18(1):5-17
This paper reviews history of new drug development in Korea as well as researchs on development of new psychotherapeutic drug from traditional medicines or natural products in Korea. Korea has a long history of traditional medicine and accumulated knowledge of natural resources. However, only a few new drug have been developed from those natural products. Now many researchers in Korea are devoting themselves to test the possibility of natural products as antipsychotic drugs, antidepressants, anxiolytic drugs and cognitive enhancers. However, only a few graduates from traditional medical schools in Korea are engaging in research on developing new drug from natural products and they are not familiar to research methods of western medicine and pharmacology. For research and development of new drug from natural products or traditional medicines, many researchers should be trained for methodology of basic medicine, pharmacology, pharmacognosy, and oriential pharmacy. Government and pharmaceutical companies need to provide more investment for R & D for new drug from natural products including establishment of data base for component of traditional medicines and natural products, system development integrating information technology, bio-technology and nanotechnology, and international collaboration with advanced countries which have common interest in new drug development from natural products.
Antidepressive Agents
;
Antipsychotic Agents
;
Biological Products
;
Natural Resources
;
Cooperative Behavior
;
Investments
;
Korea
;
Medicine, Korean Traditional
;
Medicine, Traditional
;
Nanotechnology
;
Nootropic Agents
;
Pharmacognosy
;
Pharmacology
;
Pharmacy
;
Schools, Medical
5.Modified sanjiasan decoction in regulating intelligence state of patients with vascular dementia.
Tao LIU ; Can-hui WANG ; Jin YANG
Chinese Journal of Integrated Traditional and Western Medicine 2005;25(6):492-495
OBJECTIVETo investigate the therapeutic effects of modified Sanjiasan decoction (MSD) on vascular dementia (VD).
METHODSThirty-seven patients in the treated group were given MSD, one dosage each day, and 31 patients in the control group were administered orally Naofukang 0.8 g three times a day. The treatment course for both groups was three months. The indices as Hasegawa dementia scale (HDS), mini mental state examination (MMSE) and its subentries, intelligence quotient (IQ) and memory quotient (MQ) were examined.
RESULTSMSD could improve the scores of HDS, MMSE and its subentries (P<0.05 or P<0.01), ameliorate dementia state and enhance IQ (P<0.05) and MQ (P<0.01) in patients with VD.
CONCLUSIONMSD has a certain effect on intelligence benefiting and dementia antagonizing.
Aged ; Dementia, Vascular ; drug therapy ; Female ; Humans ; Intelligence ; drug effects ; Intelligence Tests ; Male ; Materia Medica ; therapeutic use ; Middle Aged ; Nootropic Agents ; therapeutic use ; Phytotherapy
6.Clinical study on effect of yuantong capsule in treating vascular dementia.
Jun-shan HUANG ; Qiu-cheng LIN ; Rong-zhang HUANG
Chinese Journal of Integrated Traditional and Western Medicine 2003;23(11):815-818
OBJECTIVETo observe the clinical effect of Yuantong Capsule (YTC) in treating vascular dementia (VD).
METHODSEighty-three patients of VD were randomized on ratio of 2:1 into two groups, the 54 patients in the treated group were treated with YTC orally administered, 3 times a day, 1 capsule in each time. The remaining 29 patients in the control group were treated with Hydergine orally, 3 times a day, 2 mg in each time. The therapeutic course for both groups was 2 months.
RESULTSThe therapeutic effect in the treated group was significantly better than that in the control group, significant difference (P < 0.05 or P < 0.01) was shown in comparison of the two groups in terms of the mini-mental state examination (MMSE) and activity of daily living (ADL) test, symptoms scoring, total effective rate, and laboratory indexes findings.
CONCLUSIONThe therapeutic effect of YTC in treating VD was obvious.
Aged ; Aged, 80 and over ; Capsules ; Dementia, Vascular ; drug therapy ; Drug Therapy, Combination ; Drugs, Chinese Herbal ; therapeutic use ; Ergoloid Mesylates ; therapeutic use ; Female ; Humans ; Male ; Middle Aged ; Nootropic Agents ; therapeutic use ; Phytotherapy
7.Early application of citicoline in the treatment of acute stroke: A meta-analysis of randomized controlled trials.
Pei-yu SHI ; Xiao-cui ZHOU ; Xiao-xue YIN ; Liang-liang XU ; Xing-ming ZHANG ; Hong-ying BAI
Journal of Huazhong University of Science and Technology (Medical Sciences) 2016;36(2):270-277
This study was to evaluate the efficacy and safety of early application of citicoline in the treatment of patients with acute stroke by meta-analysis. Randomized controlled trials published until May 2015 were electronically searched in MEDLINE, Embase, the Cochrane Central Register of Controlled Trials, WHO International Clinical Trial Registration Platform, Clinical Trial.gov, and China Biology Medicine disc. Two reviewers independently screened the articles and extracted the data based on the inclusion and exclusion criteria. The quality of included articles was evaluated by using Revman5.0, and meta-analysis was performed. The results showed that 1027 articles were obtained in initial retrieval, and finally 7 articles, involving a total of 4039 cases, were included for analysis. The meta-analysis showed that no significant differences were found in the long-term mortality (OR=0.91, 95% CI 0.07 to 1.09, P=0.30), the rate of dependency (OR=1.02, 95% CI 0.87 to 1.24, P=0.85), and the effective rate (OR=0.98, 95% CI 0.84 to 1.14, P=0.82) between citicoline group and control group. The overall rate of adverse events in citicoline group was not significantly different from that in control group (P=0.30). The quality of included articles reached moderate-low level. In conclusion, citicolne cannot reduce long-term mortality and dependence rate in the treatment of acute stroke, and the effective rate of citivoline may be not better than that of controls but with reliable safety.
Aged
;
Cytidine Diphosphate Choline
;
administration & dosage
;
adverse effects
;
therapeutic use
;
Female
;
Humans
;
Male
;
Middle Aged
;
Nootropic Agents
;
administration & dosage
;
adverse effects
;
therapeutic use
;
Randomized Controlled Trials as Topic
;
Stroke
;
drug therapy
8.Clinical study of shuizhitong capsule in treating senile vascular dementia.
Chinese Journal of Integrated Traditional and Western Medicine 2004;24(8):694-697
OBJECTIVETo observe the clinical therapeutic effect of Shuizhitong capsule (SZT) in treating senile vascular dementia (VD) and on changes of related physio-chemical criteria.
METHODSEighty-five patients with VD were randomly divided into the treated group (n = 51) and the control group (n = 34) in the ratio of 3:2, treated with SZT and Piracetam respectively. Before and after treatment, the Zhang's Dementia Scoring (HDS) and Function of Social Activity Questionnaire (FAQ) scoring, cerebral blood flow and hemorrheologic properties were determined.
RESULTSSZT could significantly improve the patients' clinical symptoms, intracranial hemodynamic condition and the hyperviscosity, hypercoagulation and hyperaggregation status, lower the whole blood and plasma specific viscosity, raise the living standard of partial patients, with significant difference between before and after treatment (P < 0.05).
CONCLUSIONThe therapeutic effect of SZT in treating senile VD is definite.
Aged ; Blood Viscosity ; drug effects ; Capsules ; Cerebrovascular Circulation ; drug effects ; Dementia, Vascular ; drug therapy ; Drugs, Chinese Herbal ; therapeutic use ; Female ; Hemorheology ; drug effects ; Humans ; Male ; Middle Aged ; Nootropic Agents ; therapeutic use ; Phytotherapy
9.Research progress on Alzheimer's disease: pathogenesis and medical therapy.
Acta Academiae Medicinae Sinicae 2004;26(2):101-103
Alzheimer's disease (AD) is a common disease in elder people. Its incidence rate is about 5% in people above 60 years old. It has become an important factor that seriously impacts the development of families and society, and caused wildly attention all over the world. In this article, we discuss the mechanisms of AD in four aspects and put forward the strategies of drug therapy.
Aged
;
Alzheimer Disease
;
drug therapy
;
etiology
;
Amyloid beta-Peptides
;
metabolism
;
Amyloid beta-Protein Precursor
;
metabolism
;
Apoptosis
;
drug effects
;
Cholinesterase Inhibitors
;
therapeutic use
;
Female
;
Humans
;
Male
;
Nerve Growth Factor
;
metabolism
;
Neurofibrils
;
pathology
;
Nootropic Agents
;
therapeutic use
;
Plaque, Amyloid
;
metabolism
;
Synapses
;
pathology
10.Nootropic mechanisms of ginsenoside Rg1--influence on neuronal plasticity and neurogenesis.
Acta Pharmaceutica Sinica 2005;40(5):385-388
Acetylcholine
;
metabolism
;
Animals
;
Apoptosis
;
drug effects
;
Brain
;
metabolism
;
Ginsenosides
;
isolation & purification
;
pharmacology
;
Hippocampus
;
cytology
;
Memory
;
drug effects
;
Neuronal Plasticity
;
drug effects
;
Nootropic Agents
;
isolation & purification
;
pharmacology
;
Panax
;
chemistry
;
Plants, Medicinal
;
chemistry